Table of Contents 1 Market Overview 1.1 Cholesterol-Lowering Drugs Introduction 1.2 Market Analysis by Type 1.2.1 Overview: Global Cholesterol-Lowering Drugs Revenue by Type: 2015 VS 2019 VS 2025 1.2.2 Statins 1.2.3 Cholesterol Absorption Inhibitors 1.2.4 Fibrates 1.2.5 PCSK9 Inhibitors 1.3 Market Analysis by Application 1.3.1 Overview: Global Cholesterol-Lowering Drugs Revenue by Application: 2015 VS 2019 VS 2025 1.3.2 Hospital 1.3.3 Household 1.3.4 Other 1.4 Overview of Global Cholesterol-Lowering Drugs Market 1.4.1 Global Cholesterol-Lowering Drugs Market Status and Outlook (2015-2025) 1.4.2 North America (United States, Canada and Mexico) 1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy) 1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.5 South America, Middle East & Africa 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 AstraZeneca 2.1.1 AstraZeneca Details 2.1.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis 2.1.3 AstraZeneca SWOT Analysis 2.1.4 AstraZeneca Product and Services 2.1.5 AstraZeneca Cholesterol-Lowering Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.2 Sanofi 2.2.1 Sanofi Details 2.2.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis 2.2.3 Sanofi SWOT Analysis 2.2.4 Sanofi Product and Services 2.2.5 Sanofi Cholesterol-Lowering Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.3 Kowa 2.3.1 Kowa Details 2.3.2 Kowa Major Business and Total Revenue (Financial Highlights) Analysis 2.3.3 Kowa SWOT Analysis 2.3.4 Kowa Product and Services 2.3.5 Kowa Cholesterol-Lowering Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.4 Merck 2.4.1 Merck Details 2.4.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis 2.4.3 Merck SWOT Analysis 2.4.4 Merck Product and Services 2.4.5 Merck Cholesterol-Lowering Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.5 Novartis 2.5.1 Novartis Details 2.5.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis 2.5.3 Novartis SWOT Analysis 2.5.4 Novartis Product and Services 2.5.5 Novartis Cholesterol-Lowering Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.6 Pfizer 2.6.1 Pfizer Details 2.6.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis 2.6.3 Pfizer SWOT Analysis 2.6.4 Pfizer Product and Services 2.6.5 Pfizer Cholesterol-Lowering Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.7 Bristol-Myers Squibb 2.7.1 Bristol-Myers Squibb Details 2.7.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis 2.7.3 Bristol-Myers Squibb SWOT Analysis 2.7.4 Bristol-Myers Squibb Product and Services 2.7.5 Bristol-Myers Squibb Cholesterol-Lowering Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.8 AbbVie 2.8.1 AbbVie Details 2.8.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis 2.8.3 AbbVie SWOT Analysis 2.8.4 AbbVie Product and Services 2.8.5 AbbVie Cholesterol-Lowering Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.9 Daiichi Sankyo 2.9.1 Daiichi Sankyo Details 2.9.2 Daiichi Sankyo Major Business and Total Revenue (Financial Highlights) Analysis 2.9.3 Daiichi Sankyo SWOT Analysis 2.9.4 Daiichi Sankyo Product and Services 2.9.5 Daiichi Sankyo Cholesterol-Lowering Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.10 Amgen 2.10.1 Amgen Details 2.10.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis 2.10.3 Amgen SWOT Analysis 2.10.4 Amgen Product and Services 2.10.5 Amgen Cholesterol-Lowering Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 3 Sales, Revenue and Market Share by Manufacturer 3.1 Global Cholesterol-Lowering Drugs Sales and Market Share by Manufacturer (2018-2019) 3.2 Global Cholesterol-Lowering Drugs Revenue and Market Share by Manufacturer (2018-2019) 3.3 Market Concentration Rate 3.3.1 Top 3 Cholesterol-Lowering Drugs Manufacturer Market Share in 2019 3.3.2 Top 6 Cholesterol-Lowering Drugs Manufacturer Market Share in 2019 3.4 Market Competition Trend 4 Global Market Analysis by Regions 4.1 Global Cholesterol-Lowering Drugs Sales, Revenue and Market Share by Regions 4.1.1 Global Cholesterol-Lowering Drugs Sales and Market Share by Regions (2015-2020) 4.1.2 Global Cholesterol-Lowering Drugs Revenue and Market Share by Regions (2015-2020) 4.2 North America Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) 4.3 Europe Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) 4.4 Asia-Pacific Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) 4.5 South America Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) 4.6 Middle East and Africa Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) 5 North America by Country 5.1 North America Cholesterol-Lowering Drugs Sales, Revenue and Market Share by Country 5.1.1 North America Cholesterol-Lowering Drugs Sales and Market Share by Country (2015-2020) 5.1.2 North America Cholesterol-Lowering Drugs Revenue and Market Share by Country (2015-2020) 5.2 United States Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) 5.3 Canada Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) 5.4 Mexico Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) 6 Europe by Country 6.1 Europe Cholesterol-Lowering Drugs Sales, Revenue and Market Share by Country 6.1.1 Europe Cholesterol-Lowering Drugs Sales and Market Share by Country (2015-2020) 6.1.2 Europe Cholesterol-Lowering Drugs Revenue and Market Share by Country (2015-2020) 6.2 Germany Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) 6.3 UK Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) 6.4 France Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) 6.5 Russia Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) 6.6 Italy Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) 7 Asia-Pacific by Regions 7.1 Asia-Pacific Cholesterol-Lowering Drugs Sales, Revenue and Market Share by Regions 7.1.1 Asia-Pacific Cholesterol-Lowering Drugs Sales and Market Share by Regions (2015-2020) 7.1.2 Asia-Pacific Cholesterol-Lowering Drugs Revenue and Market Share by Regions (2015-2020) 7.2 China Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) 7.3 Japan Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) 7.4 Korea Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) 7.5 India Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) 7.6 Southeast Asia Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) 7.7 Australia Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) 8 South America by Country 8.1 South America Cholesterol-Lowering Drugs Sales, Revenue and Market Share by Country 8.1.1 South America Cholesterol-Lowering Drugs Sales and Market Share by Country (2015-2020) 8.1.2 South America Cholesterol-Lowering Drugs Revenue and Market Share by Country (2015-2020) 8.2 Brazil Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) 8.3 Argentina Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) 9 Middle East & Africa by Countries 9.1 Middle East & Africa Cholesterol-Lowering Drugs Sales, Revenue and Market Share by Country 9.1.1 Middle East & Africa Cholesterol-Lowering Drugs Sales and Market Share by Country (2015-2020) 9.1.2 Middle East & Africa Cholesterol-Lowering Drugs Revenue and Market Share by Country (2015-2020) 9.2 Saudi Arabia Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) 9.3 Turkey Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) 9.4 Egypt Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) 9.5 South Africa Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) 10 Market Segment by Type 10.1 Global Cholesterol-Lowering Drugs Sales and Market Share by Type (2015-2020) 10.2 Global Cholesterol-Lowering Drugs Revenue and Market Share by Type (2015-2020) 10.3 Global Cholesterol-Lowering Drugs Price by Type (2015-2020) 11 Global Cholesterol-Lowering Drugs Market Segment by Application 11.1 Global Cholesterol-Lowering Drugs Sales Market Share by Application (2015-2020) 11.2 Global Cholesterol-Lowering Drugs Revenue Market Share by Application (2015-2020) 11.3 Global Cholesterol-Lowering Drugs Price by Application (2015-2020) 12 Market Forecast 12.1 Global Cholesterol-Lowering Drugs Sales, Revenue and Growth Rate (2021-2025) 12.2 Cholesterol-Lowering Drugs Market Forecast by Regions (2021-2025) 12.2.1 North America Cholesterol-Lowering Drugs Market Forecast (2021-2025) 12.2.2 Europe Cholesterol-Lowering Drugs Market Forecast (2021-2025) 12.2.3 Asia-Pacific Cholesterol-Lowering Drugs Market Forecast (2021-2025) 12.2.4 South America Cholesterol-Lowering Drugs Market Forecast (2021-2025) 12.2.5 Middle East & Africa Cholesterol-Lowering Drugs Market Forecast (2021-2025) 12.3 Cholesterol-Lowering Drugs Market Forecast by Type (2021-2025) 12.3.1 Global Cholesterol-Lowering Drugs Sales Forecast by Type (2021-2025) 12.3.2 Global Cholesterol-Lowering Drugs Market Share Forecast by Type (2021-2025) 12.4 Cholesterol-Lowering Drugs Market Forecast by Application (2021-2025) 12.4.1 Global Cholesterol-Lowering Drugs Sales Forecast by Application (2021-2025) 12.4.2 Global Cholesterol-Lowering Drugs Market Share Forecast by Application (2021-2025) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Data Source 15.3 Disclaimer 15.4 About US

List of Tables Table 1. Global Cholesterol-Lowering Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025 Table 2. Breakdown of Cholesterol-Lowering Drugs by Company Type (Tier 1, Tier 2 and Tier 3) Table 3. Global Cholesterol-Lowering Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025 Table 4. Market Opportunities in Next Few Years Table 5. Market Risks Analysis Table 6. Market Drivers Table 7. AstraZeneca Basic Information, Manufacturing Base and Competitors Table 8. AstraZeneca Cholesterol-Lowering Drugs Major Business Table 9. AstraZeneca Cholesterol-Lowering Drugs Total Revenue (USD Million) (2017-2018) Table 10. AstraZeneca SWOT Analysis Table 11. AstraZeneca Cholesterol-Lowering Drugs Product and Services Table 12. AstraZeneca Cholesterol-Lowering Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 13. Sanofi Basic Information, Manufacturing Base and Competitors Table 14. Sanofi Cholesterol-Lowering Drugs Major Business Table 15. Sanofi Cholesterol-Lowering Drugs Total Revenue (USD Million) (2017-2018) Table 16. Sanofi SWOT Analysis Table 17. Sanofi Cholesterol-Lowering Drugs Product and Services Table 18. Sanofi Cholesterol-Lowering Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 19. Kowa Basic Information, Manufacturing Base and Competitors Table 20. Kowa Cholesterol-Lowering Drugs Major Business Table 21. Kowa Cholesterol-Lowering Drugs Total Revenue (USD Million) (2017-2018) Table 22. Kowa SWOT Analysis Table 23. Kowa Cholesterol-Lowering Drugs Product and Services Table 24. Kowa Cholesterol-Lowering Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 25. Merck Basic Information, Manufacturing Base and Competitors Table 26. Merck Cholesterol-Lowering Drugs Major Business Table 27. Merck Cholesterol-Lowering Drugs Total Revenue (USD Million) (2017-2018) Table 28. Merck SWOT Analysis Table 29. Merck Cholesterol-Lowering Drugs Product and Services Table 30. Merck Cholesterol-Lowering Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 31. Novartis Basic Information, Manufacturing Base and Competitors Table 32. Novartis Cholesterol-Lowering Drugs Major Business Table 33. Novartis Cholesterol-Lowering Drugs Total Revenue (USD Million) (2017-2018) Table 34. Novartis SWOT Analysis Table 35. Novartis Cholesterol-Lowering Drugs Product and Services Table 36. Novartis Cholesterol-Lowering Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 37. Pfizer Basic Information, Manufacturing Base and Competitors Table 38. Pfizer Cholesterol-Lowering Drugs Major Business Table 39. Pfizer Cholesterol-Lowering Drugs Total Revenue (USD Million) (2017-2018) Table 40. Pfizer SWOT Analysis Table 41. Pfizer Cholesterol-Lowering Drugs Product and Services Table 42. Pfizer Cholesterol-Lowering Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 43. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors Table 44. Bristol-Myers Squibb Cholesterol-Lowering Drugs Major Business Table 45. Bristol-Myers Squibb Cholesterol-Lowering Drugs Total Revenue (USD Million) (2017-2018) Table 46. Bristol-Myers Squibb SWOT Analysis Table 47. Bristol-Myers Squibb Cholesterol-Lowering Drugs Product and Services Table 48. Bristol-Myers Squibb Cholesterol-Lowering Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 49. AbbVie Basic Information, Manufacturing Base and Competitors Table 50. AbbVie Cholesterol-Lowering Drugs Major Business Table 51. AbbVie Cholesterol-Lowering Drugs Total Revenue (USD Million) (2017-2018) Table 52. AbbVie SWOT Analysis Table 53. AbbVie Cholesterol-Lowering Drugs Product and Services Table 54. AbbVie Cholesterol-Lowering Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 55. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors Table 56. Daiichi Sankyo Cholesterol-Lowering Drugs Major Business Table 57. Daiichi Sankyo Cholesterol-Lowering Drugs Total Revenue (USD Million) (2017-2018) Table 58. Daiichi Sankyo SWOT Analysis Table 59. Daiichi Sankyo Cholesterol-Lowering Drugs Product and Services Table 60. Daiichi Sankyo Cholesterol-Lowering Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 61. Amgen Basic Information, Manufacturing Base and Competitors Table 62. Amgen Cholesterol-Lowering Drugs Major Business Table 63. Amgen Cholesterol-Lowering Drugs Total Revenue (USD Million) (2017-2018) Table 64. Amgen SWOT Analysis Table 65. Amgen Cholesterol-Lowering Drugs Product and Services Table 66. Amgen Cholesterol-Lowering Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 67. Global Cholesterol-Lowering Drugs Sales by Manufacturer (2018-2019) (K MT) Table 68. Global Cholesterol-Lowering Drugs Revenue by Manufacturer (2018-2019) (USD Million) Table 69. Global Cholesterol-Lowering Drugs Sales by Regions (2015-2020) (K MT) Table 70. Global Cholesterol-Lowering Drugs Sales Market Share by Regions (2015-2020) Table 71. Global Cholesterol-Lowering Drugs Revenue by Regions (2015-2020) (USD Million) Table 72. North America Cholesterol-Lowering Drugs Sales by Countries (2015-2020) (K MT) Table 73. North America Cholesterol-Lowering Drugs Sales Market Share by Countries (2015-2020) Table 74. North America Cholesterol-Lowering Drugs Revenue by Countries (2015-2020) (USD Million) Table 75. North America Cholesterol-Lowering Drugs Revenue Market Share by Countries (2015-2020) Table 76. Europe Cholesterol-Lowering Drugs Sales by Countries (2015-2020) (K MT) Table 77. Europe Cholesterol-Lowering Drugs Sales Market Share by Countries (2015-2020) Table 78. Europe Cholesterol-Lowering Drugs Revenue by Countries (2015-2020) (USD Million) Table 79. Asia-Pacific Cholesterol-Lowering Drugs Sales by Regions (2015-2020) (K MT) Table 80. Asia-Pacific Cholesterol-Lowering Drugs Sales Market Share by Regions (2015-2020) Table 81. Asia-Pacific Cholesterol-Lowering Drugs Revenue by Regions (2015-2020) (USD Million) Table 82. South America Cholesterol-Lowering Drugs Sales by Countries (2015-2020) (K MT) Table 83. South America Cholesterol-Lowering Drugs Sales Market Share by Countries (2015-2020) Table 84. South America Cholesterol-Lowering Drugs Revenue by Countries (2015-2020) (USD Million) Table 85. South America Cholesterol-Lowering Drugs Revenue Market Share by Countries (2015-2020) Table 86. Middle East & Africa Cholesterol-Lowering Drugs Sales by Countries (2015-2020) (K MT) Table 87. Middle East & Africa Cholesterol-Lowering Drugs Sales Market Share by Countries (2015-2020) Table 88. Middle East & Africa Cholesterol-Lowering Drugs Revenue by Countries (2015-2020) (USD Million) Table 89. Middle East & Africa Cholesterol-Lowering Drugs Revenue Market Share by Countries (2015-2020) Table 90. Global Cholesterol-Lowering Drugs Sales by Type (2015-2020) (K MT) Table 91. Global Cholesterol-Lowering Drugs Sales Share by Type (2015-2020) Table 92. Global Cholesterol-Lowering Drugs Revenue by Type (2015-2020) (USD Million) Table 93. Global Cholesterol-Lowering Drugs Revenue Share by Type (2015-2020) Table 94. Global Cholesterol-Lowering Drugs Sales by Application (2015-2020) (K MT) Table 95. Global Cholesterol-Lowering Drugs Sales Share by Application (2015-2020) Table 96. Global Cholesterol-Lowering Drugs Sales Forecast by Regions (2021-2025) (K MT) Table 97. Global Cholesterol-Lowering Drugs Market Share Forecast by Regions (2021-2025) Table 98. Global Cholesterol-Lowering Drugs Sales Forecast by Type (2021-2025) (K MT) Table 99. Global Cholesterol-Lowering Drugs Market Share Forecast by Type (2021-2025) Table 100. Global Cholesterol-Lowering Drugs Sales Forecast by Application (2021-2025) Table 101. Global Cholesterol-Lowering Drugs Market Share Forecast by Application (2021-2025) Table 102. Direct Channel Pros & Cons Table 103. Indirect Channel Pros & Cons Table 104. Distributors/Traders/ Dealers List List of Figures Figure 1. Cholesterol-Lowering Drugs Picture Figure 2. Global Sales Market Share of Cholesterol-Lowering Drugs by Type in 2019 Figure 3. Statins Picture Figure 4. Cholesterol Absorption Inhibitors Picture Figure 5. Fibrates Picture Figure 6. PCSK9 Inhibitors Picture Figure 7. Cholesterol-Lowering Drugs Sales Market Share by Application in 2018 Figure 8. Hospital Picture Figure 9. Household Picture Figure 10. Other Picture Figure 11. Global Cholesterol-Lowering Drugs Market Status and Outlook (2015-2025) (USD Million) Figure 12. United States Cholesterol-Lowering Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 13. Canada Cholesterol-Lowering Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 14. Mexico Cholesterol-Lowering Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 15. Germany Cholesterol-Lowering Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 16. France Cholesterol-Lowering Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 17. UK Cholesterol-Lowering Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 18. Russia Cholesterol-Lowering Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 19. Italy Cholesterol-Lowering Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 20. China Cholesterol-Lowering Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 21. Japan Cholesterol-Lowering Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 22. Korea Cholesterol-Lowering Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 23. India Cholesterol-Lowering Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 24. Southeast Asia Cholesterol-Lowering Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 25. Australia Cholesterol-Lowering Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million) Figure 26. Brazil Cholesterol-Lowering Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 27. Egypt Cholesterol-Lowering Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 28. Saudi Arabia Cholesterol-Lowering Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 29. South Africa Cholesterol-Lowering Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 30. Turkey Cholesterol-Lowering Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 31. Global Cholesterol-Lowering Drugs Sales Market Share by Manufacturer in 2019 Figure 32. Global Cholesterol-Lowering Drugs Revenue Market Share by Manufacturer in 2019 Figure 33. Top 3 Cholesterol-Lowering Drugs Manufacturer (Revenue) Market Share in 2019 Figure 34. Top 6 Cholesterol-Lowering Drugs Manufacturer (Revenue) Market Share in 2019 Figure 35. Key Manufacturer Market Share Trend Figure 36. Global Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) (K MT) Figure 37. Global Cholesterol-Lowering Drugs Revenue and Growth Rate (2015-2020) (USD Million) Figure 38. Global Cholesterol-Lowering Drugs Revenue Market Share by Regions (2015-2020) Figure 39. Global Cholesterol-Lowering Drugs Revenue Market Share by Regions in 2018 Figure 40. North America Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) Figure 41. Europe Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) Figure 42. Asia-Pacific Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) Figure 43. South America Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) Figure 44. Middle East & Africa Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) Figure 45. North America Cholesterol-Lowering Drugs Revenue and Growth Rate (2015-2020) (USD Million) Figure 46. North America Cholesterol-Lowering Drugs Sales Market Share by Countries (2015-2020) Figure 47. North America Cholesterol-Lowering Drugs Sales Market Share by Countries in 2018 Figure 48. North America Cholesterol-Lowering Drugs Revenue Market Share by Countries (2015-2020) (USD Million) Figure 49. North America Cholesterol-Lowering Drugs Revenue Market Share by Countries in 2018 Figure 50. United States Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) (K MT) Figure 51. Canada Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) (K MT) Figure 52. Mexico Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) (K MT) Figure 53. Europe Cholesterol-Lowering Drugs Revenue and Growth Rate (2015-2020) (USD Million) Figure 54. Europe Cholesterol-Lowering Drugs Revenue Market Share by Countries (2015-2020) Figure 55. Europe Cholesterol-Lowering Drugs Revenue Market Share by Countries in 2019 Figure 56. Germany Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) (K MT) Figure 57. UK Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) (K MT) Figure 58. France Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) (K MT) Figure 59. Russia Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) (K MT) Figure 60. Italy Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) (K MT) Figure 61. Asia-Pacific Cholesterol-Lowering Drugs Revenue and Growth Rate (2015-2020) (USD Million) Figure 62. Asia-Pacific Cholesterol-Lowering Drugs Sales Market Share by Regions 2019 Figure 63. Asia-Pacific Cholesterol-Lowering Drugs Revenue Market Share by Regions 2019 Figure 64. China Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) (K MT) Figure 65. Japan Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) (K MT) Figure 66. Korea Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) (K MT) Figure 67. India Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) (K MT) Figure 68. Southeast Asia Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) (K MT) Figure 69. South America Cholesterol-Lowering Drugs Revenue and Growth Rate (2015-2020) (USD Million) Figure 70. South America Cholesterol-Lowering Drugs Sales Market Share by Countries in 2019 Figure 71. South America Cholesterol-Lowering Drugs Revenue Market Share by Countries in 2019 Figure 72. Brazil Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) (K MT) Figure 73. Argentina Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) (K MT) Figure 74. Middle East and Africa Cholesterol-Lowering Drugs Revenue and Growth Rate (2015-2020) (USD Million) Figure 75. Middle East and Africa Cholesterol-Lowering Drugs Sales Market Share by Countries in 2019 Figure 76. Middle East and Africa Cholesterol-Lowering Drugs Revenue Market Share by Countries (2015-2020) Figure 77. Middle East and Africa Cholesterol-Lowering Drugs Revenue Market Share by Countries in 2019 Figure 78. Saudi Arabia Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) (K MT) Figure 79. Egypt Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) (K MT) Figure 80. Turkey Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) (K MT) Figure 81. South Africa Cholesterol-Lowering Drugs Sales and Growth Rate (2015-2020) (K MT) Figure 82. Global Cholesterol-Lowering Drugs Sales and Growth Rate (2021-2025) (K MT) Figure 83. Global Cholesterol-Lowering Drugs Revenue and Growth Rate (2021-2025) (USD Million) Figure 84. North America Sales Cholesterol-Lowering Drugs Market Forecast (2021-2025) (K MT) Figure 85. Europe Sales Cholesterol-Lowering Drugs Market Forecast (2021-2025) (K MT) Figure 86. Asia-Pacific Sales Cholesterol-Lowering Drugs Market Forecast (2021-2025) (K MT) Figure 87. South America Sales Cholesterol-Lowering Drugs Market Forecast (2021-2025) (K MT) Figure 88. Middle East & Africa Sales Cholesterol-Lowering Drugs Market Forecast (2021-2025) (K MT) Figure 89. Sales Channel: Direct Channel vs Indirect Channel

AstraZeneca Sanofi Kowa Merck Novartis Pfizer Bristol-Myers Squibb AbbVie Daiichi Sankyo Amgen